Categories AlphaGraphs, Consumer, Earnings, Health Care
Key highlights from Kimberly-Clark (KMB) Q4 2020 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported fourth-quarter 2020 earnings results today.
Net sales increased 6% to $4.8 billion year-over-year.
Net income attributable to Kimberly-Clark dropped 1% to $539 million, or $1.59 per share. Adjusted EPS was $1.69.
For full-year 2020, the company expects reported net sales to grow 4-6% and organic sales to grow 1-2%. The adjusted EPS is projected to be $7.75-8.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
